IP Verse

Compositions And Methods Of Using Nintedanib For Treating Ocular Diseases With Abnormal Neovascularization - EP3463315

PATENT ANALYSIS

Patent Details

Grant Date
Jun 14, 2023
Company
ADS THERAPEUTICS LLC
Oppositions

MARGARET DIXON LIMITED

More patents of Ads Therapeutics Llc

EP3463315

Want to monitor this patent?

Feel free to send us a message here and we will get back to you